The results of the use of antilymphocytic globulins in human kidney transplantation.
D000293:Adolescent; D000328:Adult; D000818:Animals; D001706:Biopsy; D002102:Cadaver; D005260:Female; D005455:Fluorescent Antibody Technique; D005500:Follow-Up Studies; D006084:Graft Rejection; D006650:Histocompatibility Testing; D006736:Horses; D006801:Humans; D007166:Immunosuppressive Agents; D007239:Infections / Q000209:etiology; D007273:Injections, Intramuscular; D007677:Kidney Function Tests; D016030:Kidney Transplantation; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008722:Methods; D008875:Middle Aged; D011182:Postoperative Care; D011183:Postoperative Complications / Q000401:mortality; D013897:Thoracic Duct; D014019:Tissue Donors; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D005719:gamma-Globulins
D007166:Immunosuppressive Agents; D005719:gamma-Globulins